(Q81711726)
Statements
Yttrium-90 (90Y) ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-Cell non-Hodgkin's lymphoma (English)
Gregory A Wiseman
scientific article published on 01 April 2005